周围T细胞淋巴瘤:下一步是什么?
1Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Hematological oncology
|June 15, 2025
概括
周围T细胞淋巴瘤 (PTCL) 是复杂的,有超过30种亚型. 未来的治疗需要生物洞察力,超越标准化疗,如CHOP,除了特殊情况下,如性大细胞淋巴瘤 (ALCL).
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 周围T细胞淋巴瘤 (PTCL) 是一种罕见的,异质的癌症,有30多种亚型.
- 目前的治疗方法通常使用CHOP疗法,最初是针对B细胞淋巴瘤的,在PTCL中成功程度有限.
- PTCL的复杂性反映了其多样化的遗传和生物基础.
研究的目的:
- 审查PTCL的分类和治疗格局.
- 突出目前实证治疗策略的局限性.
- 倡导以生物为导向的PTCL未来治疗方法.
主要方法:
- 对PTCL分类和治疗研究的文献综述.
- 对临床试验结果的分析,包括ECHELON-2试验.
- 讨论影响治疗反应的生物多样性.
主要成果:
- 国际共识分类 (ICC) 和WHO-HEM 2022承认超过30种PTCL亚型.
- 基于CHOP的标准疗法在PTCL亚型中显示出有限的疗效.
- 在ECHELON-2试验中,brentuximab vedotin (BV) 在特定的PTCL亚型的形大细胞淋巴瘤 (ALCL) 中取得了成功.
结论:
- 未来的PTCL治疗策略必须通过对疾病生物学有更深入的理解来告知.
- 依靠从其他淋巴瘤中推断出的经验方法是不够的.
- 个性化,生物驱动的疗法对于改善PTCL的结果至关重要.
更多相关视频
07:39Isolation of CD4+ T-cells and Analysis of Circulating T-follicular Helper cTfh Cell Subsets from Peripheral Blood Using 6-color Flow Cytometry
Published on: January 7, 2019
12.4K
09:04Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
713
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Primary Lymphoid Organs
7.4K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
7.4K
Lymphoid Cells and Tissues
1.6K
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
1.6K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
